NXTC – Nextcure Inc
NextCure, Inc.NXTC
$0.4953Name : NextCure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $13,893,264.00
EPSttm : -1.77
NextCure, Inc.
$0.4953
0.04%$0.0002Float Short %
1.48
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.01
EPS Last/This Y
0.4
EPS This/Next Y
0.16
Price
0.49
Target Price
3
Analyst Recom
1
Performance Q
-33.96
Relative Volume
0.39
Beta
1.08
Ticker: NXTC
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | NXTC | 0.3864 | 0.00 | 0.00 | 40 |
| 2025-05-09 | NXTC | 0.4164 | 0.00 | 0.00 | 40 |
| 2025-05-12 | NXTC | 0.4101 | 0.00 | 0.00 | 40 |
| 2025-05-13 | NXTC | 0.4439 | 0.00 | 0.00 | 41 |
| 2025-05-14 | NXTC | 0.4444 | 0.00 | 0.00 | 41 |
| 2025-05-15 | NXTC | 0.4282 | 0.00 | 0.00 | 41 |
| 2025-05-16 | NXTC | 0.4381 | 0.00 | 0.00 | 41 |
| 2025-05-19 | NXTC | 0.45 | 0.00 | 0.00 | 41 |
| 2025-05-20 | NXTC | 0.4927 | 0.00 | 0.00 | 41 |
| 2025-05-21 | NXTC | 0.5069 | 0.00 | 0.00 | 41 |
| 2025-05-22 | NXTC | 0.499 | 0.00 | 0.00 | 41 |
| 2025-05-23 | NXTC | 0.5021 | 0.00 | 0.00 | 41 |
| 2025-05-27 | NXTC | 0.491 | N/A | N/A | 0 |
| 2025-05-28 | NXTC | 0.45 | N/A | N/A | 0 |
| 2025-05-29 | NXTC | 0.4896 | 0.00 | 0.00 | 41 |
| 2025-05-30 | NXTC | 0.4921 | 0.00 | 0.00 | 41 |
| 2025-06-02 | NXTC | 0.4994 | 0.00 | 0.00 | 41 |
| 2025-06-03 | NXTC | 0.474 | 0.00 | 0.00 | 41 |
| 2025-06-04 | NXTC | 0.478 | 0.00 | 0.00 | 43 |
| 2025-06-05 | NXTC | 0.4976 | 0.00 | 0.00 | 43 |
| 2025-06-06 | NXTC | 0.5 | 0.00 | 0.00 | 43 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | NXTC | 0.38 | 22.7 | - | -1.75 |
| 2025-05-09 | NXTC | 0.45 | 22.7 | - | -1.58 |
| 2025-05-12 | NXTC | 0.43 | 22.7 | - | -1.58 |
| 2025-05-13 | NXTC | 0.45 | 30.0 | - | -1.58 |
| 2025-05-14 | NXTC | 0.43 | 30.0 | - | -1.58 |
| 2025-05-15 | NXTC | 0.43 | 30.0 | - | -1.58 |
| 2025-05-16 | NXTC | 0.44 | 30.0 | - | -1.58 |
| 2025-05-19 | NXTC | 0.45 | 30.0 | - | -1.58 |
| 2025-05-20 | NXTC | 0.51 | 30.0 | - | -1.58 |
| 2025-05-21 | NXTC | 0.51 | 30.0 | - | -1.58 |
| 2025-05-22 | NXTC | 0.50 | 30.0 | - | -1.58 |
| 2025-05-23 | NXTC | 0.50 | 30.0 | - | -1.58 |
| 2025-05-27 | NXTC | 0.49 | 30.0 | - | -1.58 |
| 2025-05-28 | NXTC | 0.46 | 30.0 | - | -1.58 |
| 2025-05-29 | NXTC | 0.50 | 30.0 | - | -1.58 |
| 2025-05-30 | NXTC | 0.49 | 30.0 | - | -1.58 |
| 2025-06-02 | NXTC | 0.48 | 30.0 | - | -1.58 |
| 2025-06-03 | NXTC | 0.47 | 30.0 | - | -1.58 |
| 2025-06-04 | NXTC | 0.47 | 30.0 | - | -1.58 |
| 2025-06-05 | NXTC | 0.50 | 30.0 | - | -1.58 |
| 2025-06-06 | NXTC | 0.49 | 30.0 | - | -1.58 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | NXTC | 0.00 | -15.92 | 0.16 |
| 2025-05-09 | NXTC | 0.00 | -15.92 | 0.16 |
| 2025-05-12 | NXTC | 0.00 | -21.22 | 0.84 |
| 2025-05-13 | NXTC | 0.00 | -21.22 | 0.84 |
| 2025-05-14 | NXTC | 0.00 | -21.22 | 0.84 |
| 2025-05-15 | NXTC | 0.00 | -21.22 | 0.84 |
| 2025-05-16 | NXTC | 0.00 | -21.22 | 0.84 |
| 2025-05-19 | NXTC | 0.00 | -29.77 | 0.85 |
| 2025-05-20 | NXTC | 0.00 | -29.77 | 0.85 |
| 2025-05-21 | NXTC | 0.00 | -29.77 | 0.85 |
| 2025-05-22 | NXTC | 0.00 | -29.77 | 0.85 |
| 2025-05-23 | NXTC | 0.00 | -29.77 | 0.85 |
| 2025-05-27 | NXTC | 0.00 | -7.22 | 0.85 |
| 2025-05-28 | NXTC | 0.00 | -7.22 | 1.48 |
| 2025-05-29 | NXTC | 0.00 | -7.22 | 1.48 |
| 2025-05-30 | NXTC | 0.00 | -7.22 | 1.48 |
| 2025-06-02 | NXTC | 0.00 | -7.22 | 1.48 |
| 2025-06-03 | NXTC | 0.00 | -7.22 | 1.48 |
| 2025-06-04 | NXTC | 0.00 | -7.22 | 1.48 |
| 2025-06-05 | NXTC | 0.00 | -7.22 | 1.48 |
| 2025-06-06 | NXTC | 0.00 | -7.22 | 1.48 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.39
Avg. EPS Est. Current Quarter
-0.39
Avg. EPS Est. Next Quarter
-0.39
Insider Transactions
Institutional Transactions
-7.22
Beta
1.08
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
6
Growth Score
20
Sentiment Score
7
Actual DrawDown %
98.5
Max Drawdown 5-Year %
-99.1
Target Price
3
P/E
Forward P/E
PEG
P/S
P/B
0.25
P/Free Cash Flow
EPS
-1.77
Average EPS Est. Cur. Y
-1.58
EPS Next Y. (Est.)
-1.43
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.39
Return on Equity vs Sector %
-112.7
Return on Equity vs Industry %
-94.7
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.16
EBIT Estimation
NextCure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 43
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading